A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell–dependent murine model of allergic asthma
- 1 February 2013
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 131 (2) , 501-511.e1
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent mannerCellular Signalling, 2011
- The outs and the ins of sphingosine-1-phosphate in immunityNature Reviews Immunology, 2011
- An Emerging Role for the Lipid Mediator Sphingosine-1-Phosphate in Mast Cell Effector Function and Allergic Disease2011
- Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2Nature, 2010
- The many paths to asthma: phenotype shaped by innate and adaptive immunityNature Immunology, 2010
- Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-PhosphateScience, 2009
- New developments in mast cell biologyNature Immunology, 2008
- The alliance of sphingosine-1-phosphate and its receptors in immunityNature Reviews Immunology, 2008
- Immunomodulatory mast cells: negative, as well as positive, regulators of immunityNature Reviews Immunology, 2008
- Activation and Localization of Transcription Factor, Nuclear Factor- κ B, in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998